The HeartWare HVAD System (Medtronic) is a durable left ventricular assist device (LVAD)
approved for bridge to transplant indication in 2012 and destination therapy indication in …

Pregnancy after thoracic organ transplantation is feasible for select individuals but requires
multidisciplinary subspecialty care. Key components for a successful pregnancy after lung or …

Aims Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing
discussion if and which patients require prophylactically exchange for a HeartMate 3 (HM3) …

Left ventricular assist device (LVAD) implantation is one of the mechanical circulatory
support (MCS) treatments for advanced heart failure (HF) patients. MCS has emerged as a …

Background: The ideal timing of a durable assist device implantation in patients with end-
stage heart failure presenting with INTERMACS profile I is still controversial. The data on …

Background Pump exchange is an established strategy to treat LVAD‐related complications
such as thrombosis, infection, and driveline failure. Pump upgrades with an exchange to …

Cardiac output (CO) measurement by continuous pulmonary artery thermodilution (CO CTD)
has been studied in patients with pulsatile-flow LVADs (left ventricular assist devices) …

Background Pump exchange surgery of left ventricular assist device (LVAD) has been
demonstrated in several studies; however, information for Asian patients was limited. Case …

The use of left ventricular assist devices (LVADs) is intended to treat patients with end-stage
heart failure. Owing to technological advances, these devices are becoming more durable …

Abstract Since 2007, the Branislav “Brano” Radovancevic Heart Failure Forum has been
held annually to provide a venue for experts to present and discuss “Innovations and New …